R&D Trends

NY Genome Center receives $3 million grant, creates 500 jobs

Monday, April 9, 2012 12:20 PM

The Alfred P. Sloan Foundation has given a $3 million grant to independent non-profit New York Genome Center (NYGC) to help build the infrastructure needed to support a large-scale genome sequencing and bioinformatics facility for translational research.

More... »

NeuroSigma awarded $680,000 NIH grant for TFN-covered stent

Monday, April 9, 2012 10:39 AM

NeuroSigma, a Los Angeles-based medical device company, has been awarded a phase I NIH-STTR grant from the National Institute of Neurological Disorders and Stroke (NINDS) for the further development of its Thin-Film Nitinol (TFN)-covered stent for the potential treatment of brain aneurysms. 

More... »

Biocon opens research center in India, seeks 300 scientists

Friday, April 6, 2012 01:00 PM

Biocon, an Asia-based biotech, has opened the doors of its Integrated Research and Development Centre, Biocon Research Centre (BRC) in India, aimed at pursuing world class research on biologics that will address unmet medical needs.

More... »

Takeda joins SGC, funds drug research

Friday, April 6, 2012 11:34 AM

Takeda Pharmaceutical has joined the Structural Genomics Consortium (SGC), based at the Universities of Toronto and Oxford, England, to fund collective drug research aimed at bringing new, more effective medicines to market faster.

More... »

Burrill wraps up life sciences industry for Q1 2012

Wednesday, April 4, 2012 03:00 PM

Burrill & Company, a diversified global financial services firm focused on the life sciences industry, has identified more than $2.6 billion in expected funding through nine translational research and early-stage initiatives announced since the end of February.

More... »

Amgen, AstraZeneca to develop and commercialize inflammation portfolio

Monday, April 2, 2012 04:38 PM

Amgen and AstraZeneca have agreed to jointly develop and commercialize five monoclonal antibodies from Amgen's clinical inflammation portfolio (AMG 139, AMG 157, AMG 181, AMG 557 and brodalumab (AMG 827)).

More... »

Daiichi forms diabetes alliance with NGM Biopharma

Friday, March 30, 2012 03:07 PM

Tokyo-based Daiichi Sankyo has formed a partnership with San Francisco-based NGM Biopharmaceuticals to research and develop new treatments for diabetes.

More... »

CPRIT gives $81 million to cancer research

Friday, March 30, 2012 02:48 PM

The Cancer Prevention and Research Institute of Texas (CPRIT) has given an excess in funding of $81 million to support cancer research and commercialization projects in Texas.

More... »

U.K. groups unveil innovative $80 million cancer fund

Friday, March 30, 2012 09:22 AM

Cancer Research Technology (CRT), Cancer Research UK's commercial arm, and the European Investment Fund (EIF) have joined together to create an $80 million investment fund to bridge the funding gap in the U.K. between cancer drug discovery and early development.

More... »

British Prime Minister issues dementia challenge

Tuesday, March 27, 2012 02:13 PM

The Prime Minister has announced his commitment to make the U.K. a world leader in the fight against dementia.

More... »